Y300-0709 Screening compound: N-({2-[(morpholin-4-yl)methyl]phenyl}methyl)-4-(2-oxopyrrolidin-1-yl)benzene-1-sulfonamide

Y300-0709 Screening compound: N-({2-[(morpholin-4-yl)methyl]phenyl}methyl)-4-(2-oxopyrrolidin-1-yl)benzene-1-sulfonamide
Y300-0709 Screening compound: N-({2-[(morpholin-4-yl)methyl]phenyl}methyl)-4-(2-oxopyrrolidin-1-yl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y300-0709
N-({2-[(morpholin-4-yl)methyl]phenyl}methyl)-4-(2-oxopyrrolidin-1-yl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y300-0709

Molecular Formula

C22H27N3O4S (C22 H27 N3 O4 S)

Compound Name

N-({2-[(morpholin-4-yl)methyl]phenyl}methyl)-4-(2-oxopyrrolidin-1-yl)benzene-1-sulfonamide

IUPAC name

N-({2-[(morpholin-4-yl)methyl]phenyl}methyl)-4-(2-oxopyrrolidin-1-yl)benzene-1-sulfonamide

SMILES

O=C(CCC1)N1c(cc1)ccc1S(NCc1c(CN2CCOCC2)cccc1)(=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.54

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.462

Distribution Coefficient, logD

2.393

Water Solubility, LogSw

-2.81

Polar Surface Area

70.454

Acid Dissociation Constant (pKa)

10.19

Base Dissociation Constant (pKb)

6.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

Y300-0709 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with Y300-0709 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y300-0709?
Check Price and Availability of Y300-0709, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y300-0709 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y300-0709
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y300-0709
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y300-0709 available by request